Ashwagandha has become one of the most popular herbal supplements in the US, mostly for stress and sleep, and in short trials it is usually well tolerated. Yet Denmark treats it as illegal to sell in food and supplements, the Netherlands has advised people not to use it, and doctors have published a growing number of liver injury cases. So which is it?
The honest answer is that ashwagandha appears to be well tolerated by most healthy adults for up to about 3 months, but it has real, if uncommon, risks, and several groups of people should avoid it. This guide covers the liver cases, the thyroid and hormone effects, pregnancy, drug interactions, what regulators in different countries have decided and why, and how to lower your risk if you take it. For what ashwagandha does, see our guides to ashwagandha for sleep and supplements for stress.
The short version
- Usually well tolerated in short trials. In 23 randomized trials in generally healthy adults, most lasting 12 weeks or less at 125 to 600 mg a day of root extract, side effects were mild and occurred in both the ashwagandha and comparison groups.
- Liver injury is rare but real. A 2026 review counted 25 patients in published English-language reports through 2025, and regulators have received more reports that were never published. Most cases involved jaundice and itching after weeks of use. Most recovered after stopping; there has been one liver transplant, and the reported deaths were in people who already had cirrhosis. The true frequency is unknown.
- It can nudge thyroid hormones up. Pooled trials show a small rise in T4, and a few people have developed thyrotoxicosis (too much thyroid hormone). This matters if you have thyroid disease or take thyroid medicine.
- It is not advised in pregnancy or breastfeeding, mainly because safety has not been shown, not because harm has been proven.
- Regulators disagree. Denmark treats it as illegal to sell, several European agencies advise certain groups to avoid it, Australia issued safety alerts about very rare liver injury, and in the US it remains an ordinary supplement.
- Avoid it if you have liver disease, are pregnant or breastfeeding, have a thyroid condition or hormone-sensitive cancer, or take sedatives, thyroid medicine or immunosuppressants, unless your doctor agrees.
Ashwagandha safety at a glance
| Concern | What the evidence shows | Who it matters for most |
|---|---|---|
| Liver injury | Rare; at least 25 published cases; usually reversible | Anyone taking it; severe outcomes mainly in people with existing liver disease |
| Thyroid | Small T4 rise in pooled trials; a few cases of overactive thyroid | Thyroid disease, thyroid medicine |
| Sex hormones | Testosterone and DHEA-S rose modestly in men | Hormone-sensitive cancers (a precaution) |
| Pregnancy | Safety not shown; harm not proven | Pregnant and breastfeeding women |
| Common side effects | Drowsiness, stomach upset, loose stools, headache; similar to placebo in trials | Anyone, especially with sedatives or alcohol |
| Long-term use | Most trials last 12 weeks or less; one uncontrolled 12-month study | Anyone taking it for many months |
Sources for each row are discussed below.
Can ashwagandha damage your liver?
Yes, rarely. The NIH's LiverTox database rates ashwagandha as a "likely cause of clinically apparent liver injury" and describes a recognizable pattern: injury appearing "2 to 12 weeks after starting ashwagandha usually with a cholestatic or mixed pattern of injury, jaundice, and pruritus" (itching). Cholestatic means bile flow is disrupted.
- The first case series (2020) described five people from Iceland and the US Drug-Induced Liver Injury Network who took ashwagandha capsules at 450 to 1,350 mg a day. All developed jaundice 2 to 12 weeks after starting. None had liver failure, and liver tests returned to normal within 1 to 5 months in the four who were followed up. Testing confirmed ashwagandha in the products that were available, with no other toxins found, though four of the five also took other supplements.
- An Indian case series (2023) described eight cases linked to ashwagandha alone, mostly from root powders and traditional preparations, some taken at several grams a day, rather than standardized extracts. Five had underlying liver disease, and the three who presented with liver failure on top of chronic liver disease died.
- A 2026 review of published reports counted 25 patients in 13 publications. Most recovered over weeks to months. There was one liver transplant, and the three deaths were all in people with pre-existing cirrhosis.
Regulators have seen similar reports. Australia's Therapeutic Goods Administration counted 11 possible liver injury reports as of July 2026, with no deaths or transplants in Australian consumers, and described the risk as "very rare." The Netherlands' pharmacovigilance center had 12 liver injury reports by mid-2025, and Italy's surveillance system recorded 15 reports of suspected reactions, one involving liver failure needing hospital care.
How common is it? In our searches through November 2026, no study had estimated a rate, so the honest answer is that it is rare and the true frequency is unknown. Liver injury like this is idiosyncratic: it affects a small number of susceptible people unpredictably, so trials of a few dozen or a few hundred people would not be expected to catch it. The doses in reported cases overlapped ordinary label doses. LiverTox advises that ashwagandha "should be avoided in patients with cirrhosis or advanced chronic liver disease" and that people who reacted should not take the same product again. To be safe, anyone who had liver injury on ashwagandha should avoid it entirely.
Ashwagandha and your thyroid
Ashwagandha can push thyroid hormone levels up. That matters most for people who have a thyroid condition or take thyroid medicine.
- In a small trial in people with mildly abnormal thyroid tests: a 2018 trial in 50 adults with subclinical hypothyroidism found that 600 mg a day of root extract for 8 weeks lowered TSH and raised T3 and T4 compared with placebo. It was a single small pilot trial. It shows that ashwagandha can shift thyroid hormones, not that it treats thyroid disease, and thyroid conditions should be managed by a doctor.
- In pooled trials: a 2026 meta-analysis of 23 hormone trials found a small rise in T4, with no significant change in TSH or T3. In an earlier trial in bipolar disorder, the three people on ashwagandha with abnormal thyroid values all had T4 rises of 7 to 24 percent.
- In healthy adults: an 8-week trial in 80 healthy volunteers taking 600 mg a day found no significant change in thyroid hormones.
- Case reports: at least three people developed thyrotoxicosis (an overactive thyroid) while taking ashwagandha, including a 73-year-old woman who had taken it for two years to treat her own underactive thyroid and developed a fast heart rhythm. All improved after stopping.
If you have hyperthyroidism or take levothyroxine or other thyroid medicine, ashwagandha could add to the effect. Talk with your doctor first, and ask about rechecking your thyroid levels if you take it. See our guide to supplements and thyroid health.
Testosterone and other hormones
Several trials found modest rises in testosterone and DHEA-S in men. In a 2019 crossover trial of a Shoden extract in 57 overweight men aged 40 to 70 (43 completed both phases), salivary DHEA-S rose 18 percent and testosterone 14.7 percent more on ashwagandha than on placebo. A 2026 meta-analysis found testosterone rose by about 57 ng/dL in men but not in women.
In our searches through November 2026, we found no study showing harm from this, but the NIH Office of Dietary Supplements notes that, according to experts, ashwagandha might not be safe for men with hormone-sensitive prostate cancer, and the NIH's LactMed database says such men should use it cautiously. Treat that as a precaution: if you have a hormone-sensitive cancer or take hormone therapy, ask your oncologist first.
Pregnancy and breastfeeding
Ashwagandha is widely advised against in pregnancy. Denmark's 2020 risk assessment cited reports that women have used the root to induce abortion, and noted that no study has set a level below which such an effect would not occur. France, Germany and the Netherlands all advise pregnant women not to take it, as does the World Health Organization, according to Denmark's assessment.
The evidence of actual harm is thin. A 2026 review, led by an employee of a supplement company, traced the abortion claims to old ethnobotanical reports with poor primary sourcing. The NIH Office of Dietary Supplements also notes that the American Herbal Pharmacopoeia, an older source for the claim, has said there is no evidence that the root causes abortions. Two rat studies found no fetal toxicity at high doses. One small open-label trial in 70 women in the second trimester (63 completed 12 weeks) reported no adverse events, but it was too small and short to establish safety, did not report birth outcomes, and used an extract supplied by its maker. The responsible conclusion is that safety in pregnancy has not been shown, so avoid it.
For breastfeeding, there are no data on whether ashwagandha passes into breast milk, and the NIH's LactMed database says it "should be avoided, especially while nursing a newborn or preterm infant." See our guide to supplements during pregnancy.
Common side effects and rare reactions
In trials, the most common side effects are drowsiness, stomach upset, loose stools, nausea and headache. A 2026 review of 23 randomized trials, most of them placebo-controlled, in more than 2,300 generally healthy adults, most of them 12 weeks or shorter, found no serious adverse events attributed to ashwagandha. Mild side effects occurred in both the ashwagandha and comparison groups, but the trials reported them too inconsistently to pool. In the largest trial, about 1,000 people, side effects were reported by 5.2 percent on ashwagandha and 7.8 percent on placebo. Several authors of that review have ties to supplement companies.
The longest study followed 191 adults taking 600 mg a day for 12 months, without a placebo group. About 9 percent reported mild side effects, most often nausea, and liver and thyroid tests stayed in normal ranges. The extract was supplied by its manufacturer.
Rare reactions reported in single cases include dangerously low sodium from adrenal insufficiency, confusion with memory loss, a movement disorder (acute dystonia), and a recurring skin reaction that returned when the person took ashwagandha again. Single case reports cannot prove cause, but they are worth knowing if you develop unusual symptoms.
Drug interactions
Most interaction warnings are based on how ashwagandha works rather than on studies of the combination:
- Sedatives, sleep medicines and alcohol: ashwagandha can cause drowsiness, so effects may add up.
- Thyroid medicine: because it can raise thyroid hormones, it may add to levothyroxine. There are case reports of overactive thyroid in people taking ashwagandha, but in our searches through November 2026 we found no study of the combination.
- Immunosuppressants: lab and animal studies suggest effects on the immune system, which could work against drugs used after transplants or for autoimmune disease. This is theoretical.
- Diabetes and blood pressure medicines: possible additive effects; monitor if you combine them.
- Antidepressants: a Polish review of adverse event reports described side effects in people combining ashwagandha with several antidepressants. That is weak evidence, but worth mentioning to your prescriber.
If you take any prescription medicine, check with your pharmacist before starting. Our supplement and drug interactions guide covers more.
Why Denmark restricted it, and what other countries decided
Denmark. In May 2020 the Technical University of Denmark assessed ashwagandha root for the Danish Veterinary and Food Administration. Its main concerns were possible effects on sex hormones and the thyroid, the reports of use to induce abortion, and immune and nervous system effects in animal studies. Its key conclusion was that, on the available data, no intake level could be set "below which the intake will be without risk of harmful effects" (our translation from Danish). The Danish agency now states that ashwagandha is illegal to sell as a food or supplement in Denmark. This is usually reported as a 2023 ban, although in our searches through November 2026 we could not find a dated legal instrument. Liver injury was not one of the main reasons.
Pushback. India's Ministry of Ayush convened an expert committee, which said in 2024 that the studies and case reports Denmark relied on were "inconclusive" and that substantial evidence supports the safety of the root. A group of Indian Ayurveda researchers also published an editorial calling on Denmark to reconsider. As of November 2026, Denmark had not reversed it.
Other countries:
- Netherlands: the national health institute advised consumers in 2024 not to use it, especially in pregnancy. A draft Dutch rule notified to the EU in 2026 would reportedly ban all parts except the root and require warnings on root products; it is not yet in force.
- Germany: the Federal Institute for Risk Assessment advised in 2024 that children, pregnant and breastfeeding women, and people with liver disease should not take it, and that others should be cautious. Not banned.
- France: the food safety agency advised in 2024 that people with thyroid, liver or heart disease, pregnant women, people on sedatives and others should avoid it. Not banned.
- Australia: permitted, with a pregnancy warning on some products and a 2026 safety update on very rare liver injury.
- United Kingdom: the Food Standards Agency's review was still in progress as of November 2026.
- India: the Ministry of Ayush advised against using ashwagandha leaves in 2021, and in April 2026 made that a prohibition for Ayush products, citing lab studies of withaferin A, a compound concentrated in the leaves. India's food regulator circulated the same advisory for food products. Only the root may be used.
- United States: an ordinary dietary supplement ingredient. In our searches through November 2026, we found no FDA safety action specific to ashwagandha.
A common thread is that several European agencies concluded the available data were too limited to set a safe intake level, while animal studies and some human reports pointed to possible effects on hormones and the thyroid. None of them concluded that harm is widespread among users.
Root, leaf and extract type: does it matter?
Traditionally the root is used, but some extracts include leaves. KSM-66 is sold as a root-only extract, while Sensoril and Shoden use root and leaf (Sensoril's maker caps withaferin A at 0.5 percent). Leaves can contain much more withaferin A than roots, a withanolide some researchers suspect may be harmful, and India has restricted leaf use, citing it.
But in our searches through November 2026, no human case series has shown which plant part caused the liver injuries, and root products, including root powders, are among the implicated products. Australia's regulator says it is still "considering available evidence on the role of different plant parts." So a root-only product is a reasonable precaution, not a guarantee of safety. Our ashwagandha supplements ranking lists the extract type for each product.
Who should avoid it, and how to lower your risk
Avoid ashwagandha, or use it only with your doctor's agreement, if you:
- have liver disease or have had liver injury from any supplement or drug
- are pregnant, trying to conceive or breastfeeding
- have a thyroid condition or take thyroid medicine
- have a hormone-sensitive cancer, such as prostate cancer, or take hormone therapy
- have an autoimmune condition or take immunosuppressants
- take sedatives, sleep medicines or other medicines that cause drowsiness
- have surgery coming up (tell your surgical team, since it can cause drowsiness and interact with other medicines)
If you decide to take it:
- Stay near studied doses, typically 250 to 600 mg a day of a standardized root extract.
- Prefer single-ingredient products with clear labeling and third-party testing.
- Use it for a defined period, such as 8 to 12 weeks, then reassess, since long-term safety data are limited.
- Stop immediately and see a doctor if you notice yellowing skin or eyes, dark urine, itching, unusual tiredness, a racing heart or other new symptoms.
Frequently asked questions
Is ashwagandha safe to take every day?
For most healthy adults, daily use of a standardized root extract at studied doses, typically 250 to 600 mg a day, appears well tolerated for up to about 3 months. Long-term safety data are limited, rare liver injury has been reported, and some groups should avoid it, so consider taking it for a defined period and reassessing.
Can ashwagandha damage your liver?
Rarely, yes. A 2026 review counted 25 published cases through 2025, and regulators hold more unpublished reports. They usually appeared 2 to 12 weeks after starting, with jaundice and itching, though some began after months. Most people recovered after stopping, but one person needed a liver transplant, and three people who already had cirrhosis died. The true frequency is unknown. People with liver disease should avoid ashwagandha.
What are the signs of liver problems from ashwagandha?
Yellowing of the skin or eyes, dark urine, pale stools, intense itching, unusual tiredness, nausea or pain in the upper right abdomen. Stop taking it and see a doctor promptly if you notice any of these.
Does ashwagandha affect the thyroid?
It can raise thyroid hormone levels. Pooled trials show a small rise in T4, a small trial in people with mildly abnormal thyroid tests found lower TSH and higher T3 and T4, and a few people have developed an overactive thyroid. If you have thyroid disease or take thyroid medicine, talk with your doctor and ask about rechecking your levels. See our thyroid supplements guide.
Why was ashwagandha banned in Denmark?
Denmark's food agency treats ashwagandha as illegal to sell in food and supplements, based on a 2020 risk assessment that raised concerns about sex hormones, the thyroid, reported use to induce abortion and other effects, and concluded that, on the available data, no safe intake level could be set. It is usually reported as a 2023 ban. India's Ministry of Ayush has disputed the evidence behind it.
Is ashwagandha banned in the US?
No. Ashwagandha is sold as an ordinary dietary supplement ingredient in the US, and in our searches through November 2026 we found no FDA safety action specific to it.
Can you take ashwagandha while pregnant or breastfeeding?
It is not advised. Its safety in pregnancy has not been shown, several European agencies advise pregnant women not to take it, and there are no data on breastfeeding, so the NIH's LactMed database says to avoid it.
Does ashwagandha raise testosterone?
Modestly, in men. Trials found small rises in testosterone and DHEA-S in men, and a 2026 meta-analysis found testosterone rose in men but not in women. Because of this, men with hormone-sensitive prostate cancer are advised to be cautious, although, in our searches through November 2026, we found no documented harm.
Is root-only ashwagandha safer than leaf extracts?
Possibly, but it is not proven. Leaves can contain more withaferin A, and India made its leaf restriction mandatory in 2026, but no human case series has shown which plant part caused the liver injuries, and root products have also been implicated.
Who should not take ashwagandha?
People with liver disease, people who are pregnant, trying to conceive or breastfeeding, people with thyroid conditions or on thyroid medicine, people with hormone-sensitive cancers, people with autoimmune conditions or on immunosuppressants, and people taking sedatives, unless their doctor agrees.
The bottom line
For most healthy adults, ashwagandha root extract at studied doses for a few months appears to be well tolerated, with mild side effects similar to placebo in trials. But it is not risk-free. Rare liver injury is well documented, it can raise thyroid hormones, its long-term safety is not established, and it is not advised in pregnancy or breastfeeding. Regulators in Europe are more cautious than those in the US, largely because they could not set a safe intake level from the limited data.
If you are in one of the higher-risk groups, skip it or talk with your doctor first. If you take it, keep the dose and duration modest, and stop at the first sign of liver or thyroid trouble.
